Most Liquid Healthcare Companies

Cash And Equivalents
Cash And EquivalentsEfficiencyMarket RiskExp Return
1WGS GeneDx Holdings Corp
146.46 M
 0.20 
 7.58 
 1.50 
2WGSWW GeneDx Holdings Corp
146.46 M
 0.30 
 11.92 
 3.58 
3GRAL GRAIL, LLC
139.75 M
 0.09 
 3.86 
 0.34 
4FTRE Fortrea Holdings
115.57 M
(0.01)
 5.01 
(0.03)
5CVS CVS Health Corp
12.95 B
 0.05 
 2.56 
 0.12 
6CI Cigna Corp
5.92 B
(0.06)
 1.70 
(0.10)
7LLY Eli Lilly and
2.07 B
(0.20)
 1.81 
(0.36)
8BDX Becton Dickinson and
1.42 B
(0.06)
 1.17 
(0.07)
9BNR Burning Rock Biotech
1.15 B
 0.02 
 7.54 
 0.17 
10A Agilent Technologies
1.05 B
(0.04)
 1.62 
(0.06)
11HIMS Hims Hers Health
194.98 M
 0.16 
 6.60 
 1.06 
12INNV InnovAge Holding Corp
184.43 M
(0.12)
 2.77 
(0.34)
13ATR AptarGroup
141.73 M
 0.20 
 1.06 
 0.22 
14IDXX IDEXX Laboratories
114.36 M
(0.09)
 1.79 
(0.17)
15HCSG Healthcare Services Group
113.38 M
 0.08 
 2.14 
 0.17 
16AMS American Shared Hospital
12.34 M
 0.05 
 2.36 
 0.11 
17LSBPW LakeShore Biopharma Co,
255.6 M
(0.07)
 11.53 
(0.84)
18IRD Opus Genetics,
36.87 M
(0.01)
 4.71 
(0.05)
19GRCE Grace Therapeutics,
26.43 M
 0.13 
 4.68 
 0.62 
20UPB Upstream Bio,
23.59 M
 0.07 
 7.21 
 0.53 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes. Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).